Sitagliptin might be a favorable antiobesity drug for new onset diabetes after a renal transplant (vol 11, pg 494, 2013)

被引:0
作者
Soliman, A. R.
机构
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:87 / 87
页数:1
相关论文
共 1 条
[1]   Sitagliptin Might Be a Favorable Antiobesity Drug For New Onset Diabetes After a Renal Transplant [J].
Soliman, Amin R. ;
Fathy, Ahmed ;
Khashab, Sahier ;
Shaheen, Noha ;
Soliman, Mahmoud A. .
EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2013, 11 (06) :494-498